Interleukin-1β Alters Hebbian Synaptic Plasticity in Multiple Sclerosis.
interleukin (IL)-1β
long-term potentiation (LTP)
multiple sclerosis (MS)
paired associative stimulation (PAS)
synaptic plasticity
transcranial magnetic stimulation (TMS)
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
23 Sep 2020
23 Sep 2020
Historique:
received:
30
07
2020
revised:
11
09
2020
accepted:
21
09
2020
entrez:
26
9
2020
pubmed:
27
9
2020
medline:
24
2
2021
Statut:
epublish
Résumé
In multiple sclerosis (MS), inflammation alters synaptic transmission and plasticity, negatively influencing the disease course. In the present study, we aimed to explore the influence of the proinflammatory cytokine IL-1β on peculiar features of associative Hebbian synaptic plasticity, such as input specificity, using the paired associative stimulation (PAS). In 33 relapsing remitting-MS patients and 15 healthy controls, PAS was performed on the abductor pollicis brevis (APB) muscle. The effects over the motor hot spot of the APB and abductor digiti minimi (ADM) muscles were tested immediately after PAS and 15 and 30 min later. Intracortical excitability was tested with paired-pulse transcranial magnetic stimulation (TMS). The cerebrospinal fluid (CSF) levels of IL-1β were calculated. In MS patients, PAS failed to induce long-term potentiation (LTP)-like effects in the APB muscle and elicited a paradoxical motor-evoked potential (MEP) increase in the ADM. IL-1β levels were negatively correlated with the LTP-like response in the APB muscle. Moreover, IL-1β levels were associated with synaptic hyperexcitability tested with paired-pulse TMS. Synaptic hyperexcitability caused by IL-1β may critically contribute to alter Hebbian plasticity in MS, inducing a loss of topographic specificity.
Identifiants
pubmed: 32977401
pii: ijms21196982
doi: 10.3390/ijms21196982
pmc: PMC7584038
pii:
doi:
Substances chimiques
IL1B protein, human
0
Interleukin-1beta
0
Types de publication
Clinical Trial
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Fondazione Italiana Sclerosi Multipla
ID : 2019/S/1 to DC
Organisme : Ministero della Salute
ID : Ricerca corrente-IRCCS Neuromed to DC
Organisme : Ministero della Salute
ID : Ricerca Finalizzata 2018, RF-2018-12366144 to DC
Organisme : Ministero della Salute
ID : Ricerca Finalizzata 2018, GR-2018-12366154 to FB
Organisme : undefined <span style="color:gray;font-size:10px;">undefined</span>
ID : 5 × 1000 grant to IRCCS Neuromed.
Références
J Neurosci. 2014 Apr 30;34(18):6146-55
pubmed: 24790185
Neurobiol Dis. 2013 Apr;52:229-36
pubmed: 23295855
Neurorehabil Neural Repair. 2019 Oct;33(10):825-835
pubmed: 31431121
Sci Rep. 2015 Aug 06;5:12726
pubmed: 26246237
Neurology. 1983 Nov;33(11):1444-52
pubmed: 6685237
Neurosci Biobehav Rev. 2014 Jun;43:88-99
pubmed: 24726576
Clin Neurophysiol. 2017 Jul;128(7):1148-1157
pubmed: 28511127
Mult Scler. 2012 Nov;18(11):1633-5
pubmed: 22419673
Brain. 2000 Mar;123 Pt 3:572-84
pubmed: 10686179
Neuroscience. 1999;93(1):57-69
pubmed: 10430470
Brain. 2003 Dec;126(Pt 12):2586-96
pubmed: 14506068
J Neurosci. 1982 Jan;2(1):32-48
pubmed: 7054394
Neuropsychopharmacology. 2011 Apr;36(5):979-92
pubmed: 21289602
Nature. 2006 Apr 20;440(7087):1054-9
pubmed: 16547515
J Physiol. 2002 Nov 15;545(1):153-67
pubmed: 12433957
Funct Neurol. 2012 Jul-Sep;27(3):163-8
pubmed: 23402677
J Neurosci. 1998 Dec 15;18(24):10464-72
pubmed: 9852584
Hippocampus. 2009 Jul;19(7):670-6
pubmed: 19115392
Ann Neurol. 2011 Feb;69(2):292-302
pubmed: 21387374
Acta Physiol Scand. 1986 Feb;126(2):317-9
pubmed: 3705989
J Neuroinflammation. 2014 Feb 18;11:32
pubmed: 24548694
Neuromolecular Med. 2014 Mar;16(1):38-51
pubmed: 23892937
J Neurosci. 2009 Mar 18;29(11):3442-52
pubmed: 19295150
Nature. 1998 Feb 26;391(6670):892-6
pubmed: 9495341
Neurology. 2010 Mar 2;74(9):728-35
pubmed: 20194911
Mult Scler. 2014 Apr;20(4):451-7
pubmed: 24263385
Ann Neurol. 2012 Jan;71(1):76-83
pubmed: 22275254
Mult Scler Relat Disord. 2020 Oct;45:102332
pubmed: 32645635
J Neurophysiol. 2003 May;89(5):2339-45
pubmed: 12612033
Proc Natl Acad Sci U S A. 1998 Jun 9;95(12):7097-102
pubmed: 9618545
Psychoneuroendocrinology. 2007 Sep-Nov;32(8-10):1106-15
pubmed: 17976923
J Physiol. 2002 Sep 1;543(Pt 2):699-708
pubmed: 12205201
Neurobiol Dis. 2011 May;42(2):177-84
pubmed: 20817092
Neural Plast. 2018 May 14;2018:8430123
pubmed: 29861718
Neurobiol Dis. 2012 May;46(2):414-24
pubmed: 22349452
J Physiol. 1993 Nov;471:501-19
pubmed: 8120818
PLoS One. 2013;8(1):e54666
pubmed: 23355887
J Physiol. 2006 Sep 1;575(Pt 2):657-70
pubmed: 16825301
Eur J Neurosci. 2018 Feb;47(3):251-257
pubmed: 29285814
Neurobiol Dis. 2007 Jul;27(1):44-53
pubmed: 17490888
Nat Rev Neurosci. 2004 Feb;5(2):97-107
pubmed: 14735113
Clin Neurophysiol. 2004 Apr;115(4):956-65
pubmed: 15003779
J Immunol. 2017 Jun 15;198(12):4553-4560
pubmed: 28583987
Brain. 2006 Oct;129(Pt 10):2709-21
pubmed: 16921180